年龄可能影响Graves病中TRAb对甲状腺功能与复发风险的作用
TRAb与甲状腺激素呈非线性关联,TRAb每升高1 U/L复发风险增加(HR 1.05,95%CI 1.02–1.08),该关联受年龄影响而非性别、种族、吸烟或甲状腺过氧化物酶抗体水平。
要点
- 初诊TRAb与甲状腺激素呈非线性关联,先升后趋平(P < 0.0001)。
- TRAb每升高1 U/L,总体复发风险增加(HR 1.05,95%CI 1.02–1.08)。
- 年轻患者中TRAb预测价值更好(HR 1.13,95%CI 1.04–1.23),老年患者无关联(HR 0.99,95%CI 0.93–1.05)。
核心结论
- 在Graves病中,年龄可影响TRAb对甲状腺功能与复发风险的作用,初诊TRAb在年轻患者中预测价值更好。
主要发现
- TRAb与甲状腺激素呈非线性关联,曲线初始为正斜率随后趋平(P < 0.0001)。
- TRAb越高复发风险越大,每1 U/L升高HR为1.05(95%CI 1.02–1.08)。
- 上述关联受年龄影响,不受性别、种族、吸烟或甲状腺过氧化物酶抗体水平影响。
- 年轻参与者中TRAb升高与甲状腺激素更高及复发风险更大相关,每1 U/L升高HR为1.13(95%CI 1.04–1.23)。
- 老年参与者中TRAb与甲状腺激素或复发风险无关联,每1 U/L升高HR为0.99(95%CI 0.93–1.05)。
临床怎么用
- 对年轻Graves病患者,初诊TRAb可用于辅助评估甲状腺功能受累程度与复发风险。
- 对老年Graves病患者,不宜单凭初诊TRAb水平预判甲状腺激素水平或复发风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Thyrotropin receptor antibodies (TRAbs) play a crucial role in the pathogenesis of Graves disease (GD). However, factors that influence the association of TRAbs with thyroid hormones and relapse risk in GD remain unclear. OBJECTIVE: We investigated the associations of TRAbs at diagnosis with thyroid hormones and relapse risk and potential factors that can influence these associations in GD. DESIGN AND SETTING: A prospective study in an endocrine center in England. PATIENTS AND MAIN OUTCOME MEASURES: Three hundred eighty-four consecutive patients with GD who had measurements of TRAbs and thyroid hormones at diagnosis. The association of TRAbs with thyroid hormones and relapse risk was assessed through linear regression and Cox proportional hazard models, adjusted for confounders. RESULTS: TRAbs were nonlinearly associated with thyroid hormones, following a curve with an initial positive slope and a subsequent flattening (P < 0.0001). Higher TRAbs were associated with greater relapse risk [hazard ratio (HR), 1.05 (95% CI, 1.02 to 1.08) per 1-U/L increase]. These associations were modified by age, but not by sex, race, smoking, or thyroid peroxidase antibody levels. In younger participants, increasing TRAbs were associated with higher thyroid hormones and greater relapse risk [HR, 1.13 (95% CI, 1.04 to 1.23) per 1-U/L increase]. In older participants, TRAbs were not associated with thyroid hormones or relapse risk [HR, 0.99 (95% CI, 0.93 to 1.05) per 1-U/L increase. CONCLUSIONS: In GD, age can influence the effect of TRAbs on thyroid function and relapse risk. TRAbs at diagnosis have better predictive value in younger patients with GD.
引用
- Bano A, Gan E, Addison C, et al. Age May Influence the Impact of TRAbs on Thyroid Function and Relapse-Risk in Patients With Graves Disease. J Clin Endocrinol Metab. 2019. PMID: 30517711. doi:10.1210/jc.2018-01738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。